BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22732796)

  • 1. Study of molecular prognostic factors Bcl-2 and EGFR in rectal mucinous carcinomas.
    Afrem G; Mogoantă SS; Secureanu FA; Olaru A; Neamţu C; Totolici BD; Ionilă M; Crăiţoiu S
    Rom J Morphol Embryol; 2012; 53(2):277-85. PubMed ID: 22732796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic role of apoptosis mediators in rectal adenocarcinoma.
    Seicean R; Crisan D; Boers JE; Mocan T; Seicean A; Funariu G; Ciuce C
    Hepatogastroenterology; 2011; 58(110-111):1490-4. PubMed ID: 21940317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and clinical significance of IGF-II mRNA and bcl-2 protein in colorectal adenocarcinomas].
    Zhang MS; Yuan HY; Xiong B; Deng Q; Tang ZJ; Xia D
    Ai Zheng; 2002 Nov; 21(11):1226-30. PubMed ID: 12526221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological prognostic indicators with colorectal mucinous carcinomas.
    Kubota K; Akasu T; Fujita S; Sugihara K; Moriya Y; Yamamoto S
    Hepatogastroenterology; 2004; 51(55):142-6. PubMed ID: 15011850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.
    Edden Y; Wexner SD; Berho M
    Colorectal Dis; 2012 May; 14(5):555-61. PubMed ID: 21689364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
    Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
    APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiological study, pathologic evaluation and prognostic factors of colorectal mucinous vs non-mucinous adenocarcinoma (a series of 196 patients)].
    Arfaoui Toumi A; Kriaa Ben Mahmoud L; Khiari M; Lahmer A; Gharbi L; Dhraïef M; Khalfallah T; Regaya Mzabi S; Bouraoui S
    Tunis Med; 2010 Jan; 88(1):12-7. PubMed ID: 20415207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-67, p53 and bcl-2 analysis in colonic versus rectal adenocarcinoma.
    Petrişor O; Giuşcă SE; Sajin M; Dobrescu G; Căruntu ID
    Rom J Morphol Embryol; 2008; 49(2):163-71. PubMed ID: 18516322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
    Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
    Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptotic proteins as prognostic markers and indicators of radiochemosensitivity in stage II/III rectal cancers.
    Fucini C; Messerini L; Saieva C; Orzalesi L; Carroni V; Bartolini N
    Colorectal Dis; 2012 Feb; 14(2):e64-71. PubMed ID: 21848899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum.
    Kang H; O'Connell JB; Maggard MA; Sack J; Ko CY
    Dis Colon Rectum; 2005 Jun; 48(6):1161-8. PubMed ID: 15868237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.
    Yacoub L; Goldman H; Odze RD
    Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human epidermal growth factor receptor-2 family in colorectal adenocarcinoma: correlation with survival and clinicopathological findings.
    Molaei M; Pejhan S; Nayer BN; Moradi A; Ghiasi S; Zali MR
    Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):289-93. PubMed ID: 19279475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
    Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
    Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviour.
    Nagtegaal I; Gaspar C; Marijnen C; Van De Velde C; Fodde R; Van Krieken H
    J Pathol; 2004 Oct; 204(2):183-92. PubMed ID: 15378567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.